Mannkind (MNKD) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,569.00 |
| Dec 31, 2025 | 17,669.00 |
| Sep 30, 2025 | -49,406.00 |
| Jun 30, 2025 | 17,163.00 |
| Mar 31, 2025 | 23,140.00 |
| Dec 31, 2024 | 17,568.00 |
| Sep 30, 2024 | 18,358.00 |
| Jun 30, 2024 | 38,529.00 |
| Mar 31, 2024 | 24,758.00 |
| Dec 31, 2023 | 594,316.00 |
| Sep 30, 2023 | -166,950.00 |
| Jun 30, 2023 | -82,257.00 |
| Mar 31, 2023 | -157,286.00 |
| Dec 31, 2022 | -66,208.00 |
| Sep 30, 2022 | -42,007.00 |
| Jun 30, 2022 | 150,803.00 |
| Mar 31, 2022 | -222,442.00 |
| Dec 31, 2021 | -72,490.00 |
| Sep 30, 2021 | 159,750.00 |
| Jun 30, 2021 | -21,685.00 |
| Mar 31, 2021 | -27,941.00 |
| Dec 31, 2020 | -68,984.00 |
| Sep 30, 2020 | 72,767.00 |
| Jun 30, 2020 | 66,424.00 |
| Mar 31, 2020 | -474,497.00 |
| Dec 31, 2019 | -156,643.00 |
| Sep 30, 2019 | 93,345.00 |
| Jun 30, 2019 | -19,096.00 |
| Mar 31, 2019 | -15,080.00 |
| Dec 31, 2018 | -582,365.00 |
| Sep 30, 2018 | 213,979.00 |
| Jun 30, 2018 | 53,229.00 |
| Mar 31, 2018 | 106,730.00 |
| Dec 31, 2017 | 80,466.00 |
| Sep 30, 2017 | 47,035.00 |
| Jun 30, 2017 | -146,425.00 |
| Mar 31, 2017 | 227,207.00 |
| Dec 31, 2016 | 77,996.00 |
| Sep 30, 2016 | -155,344.00 |